Target intelligence / Profile preview

Late cornified envelope protein 1A (LCE1A)

Target
LCE1A
Molecular classification
Other (structural protein of the cornified envelope), Late cornified envelope protein family
01

Overview

Late cornified envelope protein 1A is a structural protein encoded by the LCE1A gene, located in the late cornified envelope (LCE) gene cluster within the epidermal differentiation complex on chromosome 1[2][7]. The protein serves as a precursor for the cornified envelope of the stratum corneum, the outermost layer of the skin, and is expressed relatively late during skin development[5][6]. LCE1A is regulated by the tumor suppressor p53 and appears to play a role in modulating histone methylation by interacting with protein arginine methyltransferase 5 (PRMT5)[1]. Although not a classical drug target, its connection to epidermal differentiation, stress response (UV, DNA damage), and possible tumor suppressor functions makes it relevant for research in dermatology and cancer biology[1][2][3][6].

Other names
Late cornified envelope protein 1ALCE1ALEP1Late envelope protein 1
02

Mechanism of action

Not applicable; no approved or investigational drugs with mechanisms directly acting on LCE1A

03

Biological functions

Component/precursor of the cornified envelope of the stratum corneumInvolved in epidermal differentiation (late stage of skin formation)Modulates histone methylation via interaction with PRMT5Regulated by the p53 tumor suppressor
04

Disease associations

Cancer (potential tumor suppressor activity via p53 pathway)Cataract 31, multiple typesLeptospirosisPossibly implicated in keratinization disorders or skin barrier defects

Beyond the preview

Go deeper on Late cornified envelope protein 1A (LCE1A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Late cornified envelope protein 1A (LCE1A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call